MEG3 and hepatocellular carcinoma: Previous studies have shown that inhibition or knockdown of DNA methyltransferase 1 (DNMT1) can restore MEG3 expression in human hepatocellular carcinoma cells and hepatic stellate cells [2, 14, 15].